INGN - Inogen Inc Stock Price, Fair Value and News

8.82USD-0.13 (-1.45%)Delayed

Market Summary

USD8.82-0.13

Delayed

-1.45%

INGN Stock Price

View Fullscreen

INGN RSI Chart

INGN Valuation

Market Cap

208.0M

Price/Earnings (Trailing)

-2.15

Price/Sales (Trailing)

0.65

EV/EBITDA

-1.3

Price/Free Cashflow

-29.15

INGN Price/Sales (Trailing)

INGN Profitability

Operating Margin

40.54%

EBT Margin

-30.14%

Return on Equity

-50.38%

Return on Assets

-30.63%

Free Cashflow Yield

-3.43%

INGN Fundamentals

INGN Revenue

Revenue (TTM)

321.5M

Rev. Growth (Yr)

8.12%

Rev. Growth (Qtr)

2.81%

INGN Earnings

Earnings (TTM)

-96.7M

Earnings Growth (Yr)

28.36%

Earnings Growth (Qtr)

45.1%

Breaking Down INGN Revenue

Last 7 days

4.3%

Last 30 days

26.9%

Last 90 days

-12.1%

Trailing 12 Months

-19.3%

How does INGN drawdown profile look like?

INGN Financial Health

Current Ratio

2.7

Debt/Equity

4e-4

Debt/Cashflow

-21.03

INGN Investor Care

Shares Dilution (1Y)

1.97%

Diluted EPS (TTM)

-4.16

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	321.5M	0	0	0
2023	369.0M	349.3M	327.9M	315.7M
2022	351.5M	353.3M	365.6M	377.2M
2021	306.9M	336.8M	355.6M	358.0M
2020	360.2M	330.9M	313.4M	308.5M
2019	369.3M	373.1M	369.6M	361.9M
2018	276.0M	309.1M	335.4M	358.1M
2017	212.3M	221.9M	236.5M	249.4M
2016	168.2M	178.8M	192.4M	202.8M
2015	122.7M	136.3M	147.7M	159.0M
2014	83.3M	93.6M	103.2M	112.5M
2013	55.3M	62.0M	68.7M	75.4M
2012	0	0	0	48.6M
2009	0	0	0	10.7M

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Inogen Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
May 01, 2024	glezer stanislav	sold (taxes)	-117,700	7.05	-16,695	evp, r&d & chief med. officer
May 01, 2024	somer jason	acquired	-	-	19,276	evp, gen. counsel & secretary
May 01, 2024	somer jason	sold (taxes)	-79,749	7.05	-11,312	evp, gen. counsel & secretary
May 01, 2024	glezer stanislav	acquired	-	-	32,638	evp, r&d & chief med. officer
Mar 01, 2024	glezer stanislav	acquired	-	-	13,914	evp, r&d & chief med. officer
Mar 01, 2024	glezer stanislav	sold (taxes)	-53,551	7.025	-7,623	evp, r&d & chief med. officer
Mar 01, 2024	somer jason	sold (taxes)	-32,146	7.025	-4,576	evp, gen. counsel & secretary
Mar 01, 2024	somer jason	acquired	-	-	7,150	evp, gen. counsel & secretary
Dec 01, 2023	somer jason	sold (taxes)	-1,635	5.72	-286	evp, gen. counsel & secretary
Dec 01, 2023	somer jason	acquired	-	-	576	evp, gen. counsel & secretary

Which funds bought or sold INGN recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 16, 2024	CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM	reduced	-38.92	-2,152	18,908	-%
May 16, 2024	COMERICA BANK	unchanged	-	2,526	7,901	-%
May 16, 2024	Tidal Investments LLC	unchanged	-	45,735	147,185	-%
May 16, 2024	JANE STREET GROUP, LLC	sold off	-100	-171,924	-	-%
May 15, 2024	BOOTHBAY FUND MANAGEMENT, LLC	new	-	384,519	384,519	0.01%
May 15, 2024	GLENMEDE TRUST CO NA	unchanged	-	105,806	330,950	-%
May 15, 2024	Point72 Asset Management, L.P.	new	-	969,675	969,675	-%
May 15, 2024	OCCUDO QUANTITATIVE STRATEGIES LP	sold off	-100	-206,968	-	-%
May 15, 2024	PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO	reduced	-4.14	80,184	276,172	-%
May 15, 2024	DAFNA Capital Management LLC	added	1,291	1,602,580	1,684,940	0.38%

Are Funds Buying or Selling INGN?

Are funds buying INGN calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own INGN

No. of Funds

Unveiling Inogen Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Apr 23, 2024	divisadero street capital management, lp	5.9%	1,388,927	SC 13G
Feb 14, 2024	camber capital management lp	8.58%	2,013	SC 13G/A
Feb 14, 2024	brown capital management llc	6.69%	1,560,409	SC 13G/A
Feb 13, 2024	vanguard group inc	5.83%	1,358,072	SC 13G/A
Jan 24, 2024	blackrock inc.	9.6%	2,240,324	SC 13G/A
Jul 24, 2023	camber capital management lp	6.92%	2,013	SC 13G
Jul 10, 2023	vanguard group inc	6.40%	1,480,064	SC 13G/A
Jul 07, 2023	blackrock inc.	7.5%	1,729,549	SC 13G/A
Feb 14, 2023	brown capital management llc	7.48%	1,715,188	SC 13G/A
Feb 09, 2023	vanguard group inc	11.76%	2,694,460	SC 13G/A

Recent SEC filings of Inogen Inc

View All Filings

Date Filed	Form Type	Document
May 15, 2024	8-K	Current Report
May 14, 2024	144	Notice of Insider Sale Intent
May 14, 2024	4	Insider Trading
May 08, 2024	10-Q	Quarterly Report
May 07, 2024	8-K	Current Report
May 03, 2024	4	Insider Trading
May 03, 2024	4	Insider Trading
Apr 23, 2024	SC 13G	Major Ownership Report
Apr 18, 2024	ARS	ARS
Apr 18, 2024	DEF 14A	DEF 14A

Peers (Alternatives to Inogen Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
ABT	181.0B	40.3B	-1.75%	-4.07%	32.18	4.49	-2.84%	-3.08%
BDX	68.3B	19.7B	1.78%	-6.05%	51.24	3.46	4.82%	-17.56%
ALGN	20.4B	3.9B	-9.57%	-7.50%	44.2	5.22	5.72%	46.72%
BAX	18.0B	14.9B	-10.73%	-18.01%	6.79	1.21	2.98%	207.68%
MID-CAP
ATR	9.8B	3.5B	6.68%	24.08%	31.27	2.76	6.16%	35.06%
HSIC	9.6B	12.5B	6.31%	-2.51%	24.63	0.77	-0.61%	-18.83%
BIO	8.4B	2.6B	1.13%	-22.65%	-26.02	3.22	-6.25%	-68.62%
XRAY	5.9B	3.9B	-6.79%	-30.12%	-62.84	1.49	0.23%	91.03%
AXNX	3.4B	387.1M	0.52%	31.17%	-216.3	8.9	30.82%	65.57%
PDCO	2.3B	6.6B	0.19%	-5.50%	11.93	0.35	2.78%	-0.87%
SMALL-CAP
AHCO	1.3B	3.2B	5.94%	-10.00%	-1.91	0.41	7.94%	-1661.78%
ANIK	376.6M	169.3M	-1.13%	-2.23%	-4.9	2.23	7.49%	-244.90%
ANGO	241.9M	324.0M	-4.58%	-37.15%	-1.26	0.75	-3.19%	-337.41%
APYX	56.1M	50.5M	22.73%	-73.49%	-2.46	1.11	14.25%	-10.06%
AEMD	1.0M	3.7M	-71.13%	32.26%	-0.09	0.28	5.77%	8.23%

Inogen Inc News

Latest updates

Inogen Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

(*) denotes actual numbers (not divided by Thousands)
Income Statement (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	2.8%	78,025,000	75,896,000	83,967,000	83,635,000	72,162,000	88,091,000	105,389,000	103,376,000	80,385,000	76,403,000	93,105,000	101,563,000	86,932,000	73,978,000	74,329,000	71,691,000	88,489,000	78,917,000	91,761,000	101,063,000	90,202,000
Cost Of Revenue	-8.6%	43,654,000	47,738,000	50,203,000	49,591,000	41,429,000	58,620,000	62,591,000	57,118,000	45,379,000	37,815,000	45,418,000	51,228,000	47,059,000	39,919,000	41,323,000	38,942,000	50,123,000	44,995,000	48,446,000	50,848,000	45,793,000
Gross Profit	22.1%	34,371,000	28,158,000	33,764,000	34,044,000	30,733,000	29,471,000	42,798,000	46,258,000	35,006,000	38,588,000	47,687,000	50,335,000	39,873,000	34,059,000	33,006,000	32,749,000	38,366,000	33,922,000	43,315,000	50,215,000	44,409,000
Operating Expenses	-11.4%	50,645,000	57,140,000	80,485,000	45,812,000	52,648,000	87,960,000	53,090,000	49,134,000	48,592,000	45,261,000	41,313,000	38,664,000	42,005,000	39,581,000	34,979,000	35,100,000	40,545,000	39,243,000	35,208,000	38,070,000	39,551,000
S&GA Expenses	5.0%	26,936,000	25,653,000	26,091,000	26,906,000	28,441,000	28,606,000	33,734,000	30,388,000	28,039,000	29,706,000	28,301,000	29,317,000	25,491,000	25,389,000	22,882,000	22,086,000	27,163,000	25,544,000	24,047,000	27,758,000	28,201,000
R&D Expenses	-2.0%	6,578,000	6,714,000	4,489,000	4,293,000	5,344,000	5,934,000	4,581,000	6,064,000	5,364,000	4,684,000	3,754,000	4,123,000	4,015,000	3,674,000	3,511,000	3,290,000	3,605,000	3,628,000	2,636,000	1,468,000	1,669,000
EBITDA Margin	9.5%	-0.24	-0.27	-0.34	-0.22	-0.18	-0.16	-0.03	0.01	0.06	0.08	0.09	0.07	-	-	-	-	-	-	-	-	-
Income Taxes	71.9%	-150,000	-533,000	401,000	41,000	196,000	141,000	70,000	69,000	224,000	15,988,000	-6,245,000	6,902,000	-1,653,000	-84,000	-214,000	945,000	-98,000	-2,862,000	1,890,000	3,524,000	770,000
Earnings Before Taxes	45.6%	-14,728,000	-27,088,000	-45,318,000	-9,785,000	-20,153,000	-56,469,000	-9,436,000	-3,373,000	-13,990,000	-6,889,000	5,929,000	12,004,000	-2,385,000	-5,205,000	-1,913,000	3,525,000	-1,687,000	-4,237,000	8,753,000	13,684,000	6,072,000
EBT Margin	7.0%	-0.30	-0.32	-0.40	-0.27	-0.24	-0.22	-0.09	-0.05	-0.01	0.02	0.03	0.01	-	-	-	-	-	-	-	-	-
Net Income	45.1%	-14,578,000	-26,555,000	-45,719,000	-9,826,000	-20,349,000	-56,610,000	-9,506,000	-3,442,000	-14,214,000	-22,877,000	12,174,000	5,102,000	-732,000	-5,121,000	-1,699,000	2,580,000	-1,589,000	-1,375,000	6,863,000	10,160,000	5,302,000
Net Income Margin	7.4%	-0.30	-0.32	-0.40	-0.28	-0.24	-0.22	-0.14	-0.08	-0.06	-0.02	0.03	-0.01	-	-	-	-	-	-	-	-	-
Free Cashflow	-33.4%	-6,059,000	-4,542,000	1,477,000	1,990,000	-7,377,000	-16,049,000	-10,017,000	4,661,000	-19,464,000	5,823,000	-4,207,000	15,191,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-3.2%	316	326	344	374	386	405	470	470	475	490	513	498	476	462	460	458	459	447	445	404	388
Current Assets	-3.8%	199	207	225	269	283	305	318	315	318	329	336	328	310	306	303	303	303	292	290	341	322
Cash Equivalents	-14.4%	107	125	125	168	164	187	210	224	213	236	242	239	220	212	214	214	208	198	156	214	190
Inventory	12.6%	25.00	22.00	24.00	31.00	39.00	34.00	36.00	33.00	34.00	32.00	32.00	27.00	26.00	25.00	29.00	36.00	38.00	36.00	34.00	24.00	29.00
Net PPE	-2.1%	49.00	50.00	50.00	49.00	46.00	43.00	41.00	40.00	39.00	39.00	37.00	34.00	31.00	28.00	25.00	22.00	20.00	19.00	20.00	21.00	22.00
Goodwill	-2.2%	10.00	10.00	10.00	33.00	33.00	33.00	33.00	33.00	33.00	33.00	33.00	33.00	33.00	33.00	33.00	33.00	33.00	33.00	33.00	2.00	2.00
Liabilities	1.9%	124	121	113	100	104	108	119	114	116	119	122	127	120	112	108	107	112	103	102	70.00	66.00
Current Liabilities	2.0%	74.00	72.00	60.00	59.00	63.00	65.00	66.00	59.00	60.00	62.00	60.00	62.00	55.00	57.00	52.00	51.00	56.00	50.00	50.00	46.00	44.00
Shareholder's Equity	-6.3%	192	205	231	275	281	297	351	357	358	370	391	371	356	350	353	351	347	345	343	334	322
Retained Earnings	-12.5%	-131	-116	-90.39	-44.67	-34.85	-14.50	42.00	52.00	55.00	69.00	92.00	80.00	75.00	76.00	81.00	82.00	80.00	81.00	83.00	76.00	66.00
Additional Paid-In Capital	0.8%	323	321	322	319	316	312	309	305	302	299	297	290	280	274	271	268	267	263	260	257	255
Accumulated Depreciation	0.6%	48.00	48.00	-	-	-	52.00	51.00	51.00	51.00	52.00	50.00	49.00	47.00	46.00	45.00	45.00	46.00	45.00	44.00	43.00	43.00
Shares Outstanding	1.0%	24.00	23.00	23.00	23.00	23.00	23.00	23.00	23.00	23.00	22.00	23.00	22.00	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	268	-	-	-	311	-	-	-	853	-	-	-	406	-	-	-	811	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-50.9%	-4,749	-3,148	2,185	4,030	-6,301	-15,482	-9,483	5,531	-18,098	6,498	-2,994	17,269	2,860	16,198	6,745	13,530	540	9,389	14,601	18,427	-1,824
Share Based Compensation	328.6%	2,416	-1,057	1,779	3,263	3,442	3,098	3,500	3,020	2,665	2,396	2,792	3,239	2,516	2,092	2,050	1,277	2,784	2,199	1,565	1,779	3,586
Cashflow From Investing	-425.7%	-13,444	4,128	-45,793	-540	-17,110	-6,944	-4,755	4,874	-4,052	-12,377	1,154	-4,408	986	-18,522	-7,969	-8,048	8,899	31,452	-73,677	5,116	-6,948
Cashflow From Financing	2135.7%	285	-14.00	448	-33.00	559	-112	701	-101	-108	-30.00	4,690	5,913	4,427	84.00	946	61.00	975	982	1,329	172	2,446

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

INGN Income Statement

2024-03-31

Consolidated Statements of Comprehensive Loss (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue
Sales revenue	$ 63,095	$ 55,887
Rental revenue	14,930	16,275
Total revenue	78,025	72,162
Cost of revenue
Cost of sales revenue	35,244	33,964
Cost of rental revenue, including depreciation of $3,179 and $3,078, respectively	8,410	7,465
Total cost of revenue	43,654	41,429
Gross profit
Gross profit-sales revenue	27,851	21,923
Gross profit-rental revenue	6,520	8,810
Total gross profit	34,371	30,733
Operating expense
Research and development	6,578	5,344
Sales and marketing	26,936	28,441
General and administrative	17,131	18,863
Total operating expense	50,645	52,648
Loss from operations	(16,274)	(21,915)
Other income (expense)
Interest income, net	1,403	1,525
Other income, net	143	237
Total other income, net	1,546	1,762
Loss before provision (benefit) for income taxes	(14,728)	(20,153)
Provision (benefit) for income taxes	(150)	196
Net loss	(14,578)	(20,349)
Other comprehensive income (loss), net of tax
Change in foreign currency translation adjustment	(1,035)	170
Change in net unrealized gains (losses) on marketable securities	(2)	69
Total other comprehensive income (loss), net of tax	(1,037)	239
Comprehensive loss	$ (15,615)	$ (20,110)
Basic net loss per share attributable to common stockholders (Note 7)	$ (0.62)	$ (0.88)
Diluted net loss per share attributable to common stockholders (Note 7)	$ (0.62)	$ (0.88)
Weighted average number of shares used in calculating net loss per share attributable to common stockholders:
Basic common shares	23,401,598	23,009,617
Diluted common shares	23,401,598	23,009,617

INGN Balance Sheet

2024-03-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents	$ 107,444	$ 125,492
Marketable securities	12,361	2,979
Accounts receivable, net	40,223	42,241
Inventories, net	24,601	21,840
Income tax receivable	976	669
Prepaid expenses and other current assets	13,589	13,846
Total current assets	199,194	207,067
Property and equipment, net	49,270	50,316
Goodwill	9,834	10,057
Intangible assets, net	32,907	34,591
Operating lease right-of-use asset	20,575	20,338
Other assets	3,819	3,825
Total assets	315,599	326,194
Current liabilities
Accounts payable and accrued expenses	31,706	30,142
Accrued payroll	10,602	11,066
Warranty reserve - current	10,095	9,628
Operating lease liability - current	3,515	3,653
Earnout liability	10,570	10,000
Deferred revenue - current	7,422	7,980
Income tax payable		27
Total current liabilities	73,910	72,496
Long-term liabilities
Warranty reserve - noncurrent	15,435	13,850
Operating lease liability - noncurrent	18,595	18,270
Deferred revenue - noncurrent	7,613	8,227
Deferred tax liability	8,148	8,539
Total liabilities	123,701	121,382
Commitments and contingencies (Note 10)
Stockholders' equity
Common stock, $0.001 par value per share; 200,000,000 authorized; 23,546,478 and 23,324,750 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	24	23
Additional paid-in capital	323,213	320,513
Accumulated deficit	(131,527)	(116,949)
Accumulated other comprehensive income	188	1,225
Total stockholders' equity	191,898	204,812
Total liabilities and stockholders' equity	$ 315,599	$ 326,194

About Inogen Inc

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; and related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

CEO	Mr. Nabil Shabshab
WEBSITE	inogen.com
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	1026

Inogen Inc Frequently Asked Questions

What is the ticker symbol for Inogen Inc? What does INGN stand for in stocks?

INGN is the stock ticker symbol of Inogen Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Inogen Inc (INGN)?

As of Fri May 17 2024, market cap of Inogen Inc is 207.95 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of INGN stock?

You can check INGN's fair value in chart for subscribers.

What is the fair value of INGN stock?

You can check INGN's fair value in chart for subscribers. The fair value of Inogen Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Inogen Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for INGN so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Inogen Inc a good stock to buy?

The fair value guage provides a quick view whether INGN is over valued or under valued. Whether Inogen Inc is cheap or expensive depends on the assumptions which impact Inogen Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for INGN.

What is Inogen Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, INGN's PE ratio (Price to Earnings) is -2.15 and Price to Sales (PS) ratio is 0.65. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. INGN PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Inogen Inc's stock?

In the past 10 years, Inogen Inc has provided -0.057 (multiply by 100 for percentage) rate of return.